Log in to search using one of your social media accounts:

 

EU antitrust officials charge Teva in ‘ pay-for-delay ’ deal
Antitrust regulators in the European Union charged Teva Pharmaceuticals (NYSE:TEVA) today, accusing the company of arranging an illegal deal with Cephalon to delay the sale of a cheap generic version to Cephalon’s sleep disorder drug, modafinil. The EU competition officials have unleashed a series of fines against an array of companies in recent years over similar deals, including U.S. giant Johnson & Johnson (NYSE:JNJ). Get the full story at our sister site, Drug Delivery Business News. The post EU antitrust officials charge Teva in ‘pay-for-delay’ deal appeared first on...
Source: Mass Device - July 17, 2017 Category: Medical Devices Authors: Sarah Faulkner Tags: Legal News Pharmaceuticals Wall Street Beat cephalon johnsonandjohnson Teva Pharmaceuticals Source Type: news

Sun Pharma enters settlement in antitrust litigation in US
"Sun Pharmaceutical Industries Ltd, and one of its wholly-owned subsidiaries have entered into settlements with certain plaintiffs in re Modafinil Antitrust Litigation." (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - July 7, 2017 Category: Pharmaceuticals Source Type: news

Provigil (Modafinil) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - July 3, 2017 Category: Drugs & Pharmacology Source Type: news

Study: More Sleep, Coffee May Be Better Than Painkillers For Treating Chronic Pain
BOSTON (CBS) – Getting a good night’s rest or perking up with a cup of coffee may be a more effective way to treat chronic pain than turning to painkillers, a new study suggests. Harvard Medical School researchers at Boston Children’s Hospital and Beth Israel Deaconess Medical Center conducted their study on mice. They found that getting more sleep or taking something to feel more alert performed better than standard painkillers at treating pain sensitivity. Researchers kept the mice awake by entertaining them with toys, which is not unlike how many humans deprive themselves of sleep. They found...
Source: WBZ-TV - Breaking News, Weather and Sports for Boston, Worcester and New Hampshire - May 9, 2017 Category: Consumer Health News Authors: Health – CBS Boston Tags: Health Local News Syndicated Local Caffeine chronic pain Harvard Medical School Sleep Study Source Type: news

Cognitive enhancing drugs can improve chess play, scientists show
The first study to both show and measure the effects of cognitive-enhancing drugs such as modafinil, methylphenidate (best known under the trade name Ritalin), and caffeine, on chess play is being published. Research shows significant cognitive improvements for modafinil and methylphenidate, and may influence how these drugs are used off-label in a range of activities. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - March 6, 2017 Category: Science Source Type: news

The influence of stimulants on performance when playing chess
(Johannes Gutenberg Universitaet Mainz) High-performance tournament chess players can actually enhance the highly complex cognitive functions they require by taking substances such as the CNS stimulant methylphenidate or the wakefulness promoter modafinil and thus win more chess matches -- unless they are under time pressure. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - March 6, 2017 Category: Global & Universal Source Type: news

Scientists show cognitive-enhancing drugs can improve chess play
(European College of Neuropsychopharmacology) The first study to both show and measure the effects of cognitive-enhancing drugs such as modafinil, methylphenidate (best known under the trade name Ritalin), and caffeine, on chess play is being published in the March edition of the peer-reviewed journal European Neuropsychopharmacology. This shows significant cognitive improvements for modafinil and methylphenidate, and may have influence how these drugs are used off-label in a range of activities. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - March 6, 2017 Category: Global & Universal Source Type: news

Mylan Agreed to Pay $96.5 Mln in Provigil Antitrust Class Action Mylan Agreed to Pay $96.5 Mln in Provigil Antitrust Class Action
Mylan NV has agreed to pay $96.5 million to settle claims by drug purchasers that it delayed launching a generic version of Cephalon Inc's narcolepsy drug Provigil (modafinil) in exchange for payment from Cephalon.Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - February 7, 2017 Category: Consumer Health News Tags: Medscape Today News Source Type: news

Modafinil found to improve memory in people recovering from depression
A new study funded by the MRC and Wellcome, and published today in the journal Biological Psychiatry: Cognitive Neuroscience and Neuroimaging, has found that the wakefulness-promoting drug modafinil improves memory functions in people recovering from depression. (Source: Medical Research Council General News)
Source: Medical Research Council General News - January 17, 2017 Category: Research Source Type: news

Stimulant boosts function in patients recovering from depression
LONDON (Reuters) - People recovering from depression but struggling with its effect on memory, concentration and cognitive function may benefit from the stimulant modafinil, according to results of a small study published on Tuesday. (Source: Reuters: Health)
Source: Reuters: Health - January 17, 2017 Category: Consumer Health News Tags: healthNews Source Type: news

Clinical study suggests efficacy of modafinil to improve memory in patients with depression
A clinical study conducted by the University of Cambridge has suggested efficacy of the drug modafinil for improving memory in patients recovering from depression. (Source: Drug Development Technology)
Source: Drug Development Technology - January 17, 2017 Category: Pharmaceuticals Source Type: news

Patients recovering from depression show improvements in memory from the drug modafinil
(University of Cambridge) Modafinil, a drug used to treat narcolepsy -- excessive daytime sleepiness -- can improve memory in patients recovering from depression, according to new research from the University of Cambridge. The findings, published today in the journal Biological Psychiatry: CNNI, result from a randomized, double-blind, placebo-controlled study and offer hope of a treatment for some of the cognitive symptoms of depression. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - January 16, 2017 Category: Global & Universal Source Type: news

Warwick University experts say sleep disorder drug also reduces hunger cravings
Researchers from Warwick University and Imperial College London found giving overweight adults Modafinil, generally used to treat narcolepsy, helps to reduce impulsive behaviour. (Source: the Mail online | Health)
Source: the Mail online | Health - December 14, 2016 Category: Consumer Health News Source Type: news

Tennessee gets $3.32 million in perscription drug settlement
Tennessee will receive more than $3 million in a settlement with pharmaceutical company Cephalon, now part of Teva Pharmaceutical Industries, Attorney General Herbert H. Slatery III announced today. The settlement comes after litigation, led by the Federal Trade Commission, accused Cephalon and its competitors of anticompetitive conduct, keeping a generic version of the drug Provigil, a drug used to treat sleeping disorders, off the market for six years. Cephalon was accused of paying competi tors… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - August 5, 2016 Category: Pharmaceuticals Authors: Marissa Higdon Source Type: news

Cephalon, U.S. states reach $125 million settlement over generic drugs
WASHINGTON (Reuters) - Cephalon has reached a $125 million settlement with 48 states in connection with its alleged efforts to delay generic versions of its blockbuster sleep disorder drug Provigil from entering the market, New York Attorney General Eric Schneiderman said on Thursday. (Source: Reuters: Health)
Source: Reuters: Health - August 4, 2016 Category: Consumer Health News Tags: healthNews Source Type: news

Why 'smart drugs' can make you LESS clever
It's estimated around 20 per cent of us have taken a smart drug such as Ritalin, Modafinil or Provigil, says Nadira Faber, a research fellow in psychology at the University of Oxford. (Source: the Mail online | Health)
Source: the Mail online | Health - July 22, 2016 Category: Consumer Health News Source Type: news

modafinil, Provigil
Title: modafinil, ProvigilCategory: MedicationsCreated: 5/24/2002 12:00:00 AMLast Editorial Review: 7/11/2016 12:00:00 AM (Source: MedicineNet Sleep General)
Source: MedicineNet Sleep General - July 11, 2016 Category: Sleep Medicine Source Type: news

Provagil pill helps men with premature ejaculation and is used by students to stay up
Men who suffer from premature ejaculation can last fifteen times as long if they take Provigil, which is available for as little as 50p per pill online and often used by students to cram for exams. (Source: the Mail online | Health)
Source: the Mail online | Health - June 19, 2016 Category: Consumer Health News Source Type: news

The Slowave Movement Wants To Disrupt The Way We Think About Sleep
Sometime in the summer of 2013, a New York City-based writer named Fiona Duncan began noticing an abundance of jeans, fleece and sneakers in the historically fashion-fanatic neighborhood known as Soho. To help explain the unnerving prevalence of "stylized blandness" and "dad-brand non-style" hanging about, she borrowed -- and subsequently popularized -- a term that's all but commonplace now: normcore.  The term is simple and concise, easily packaged next to a pound sign, ready to fall from the lips of a trendy teen. Adidas tennis shoes, "Seinfeld" and President Obama all became ...
Source: Healthy Living - The Huffington Post - April 14, 2016 Category: Consumer Health News Source Type: news

Over-hyped 'smart drug' actually impairs brain function, shocked scientists discover
(NaturalNews) While some individuals -- mainly students striving to excel in classes and on exams -- have claimed that the drug Modafinil, more commonly known as the popular "smart" drug," has the ability to boost brain power, a new study shows that the drug actually does the opposite... (Source: NaturalNews.com)
Source: NaturalNews.com - January 15, 2016 Category: Consumer Health News Source Type: news

Endurance expert: Drugs could help 'lazy' people exercise
(University of Kent) Together with lack of time, physical exertion is one of the main perceived barriers to exercise. This is not surprising because humans evolved to be 'lazy', i.e. to conserve energy. Professor Samuele Marcora suggests that reducing perception of effort during exercise using caffeine or other psychoactive drugs (e.g. methylphenidate and modafinil) could help many people stick to their fitness plans. (Source: EurekAlert! - Biology)
Source: EurekAlert! - Biology - November 3, 2015 Category: Biology Source Type: news

What’s the deal with modafinil? | Archy de Berker and Sven Bestmann
Recent hype surrounding neuroenhancing drugs should set alarm bells ringing for scientists A great deal of excitement has been generated in recent weeks by a review paper examining the literature on the drug modafinil, which concluded that “modafinil may well deserve the title of the first well-validated pharmaceutical ‘nootropic’ [cognitive enhancing] agent”. Coverage in the Guardian, Telegraph, British Medical Journal, and the Independent all called attention to the work, with a press release from Oxford University trumpeting “Review of ‘smart drug’ shows modafinil does enhance c...
Source: Guardian Unlimited Science - October 5, 2015 Category: Science Authors: Archy de Berker and Sven Bestmann Tags: Science Psychology Drugs Medical research Source Type: news

Don’t judge politicians by their taste in vests | Letters
Gladstone collars, Anthony Eden hats, Wilson’s raincoats – now it’s Jeremy Corbyn vests. Why are male politicians judged by their clothing rather than their policies and principles?Robert SolomonLondon• While there is outrage at taking drugs to improve athletic performance, apparently it’s fine to take drugs to improve academic performance (Modafinil hailed as the first safe “smart drug”, 20 August).Jonathan LongLeeds Continue reading... (Source: Guardian Unlimited Science)
Source: Guardian Unlimited Science - August 24, 2015 Category: Science Authors: Letters Tags: Jeremy Corbyn Drugs in sport Genetics Source Type: news

Does "smart drug" really help people focus?
Many students pop modafinil thinking it will help them cram for finals, but evidence was lacking (Source: Health News: CBSNews.com)
Source: Health News: CBSNews.com - August 20, 2015 Category: Consumer Health News Source Type: news

Why taking smart drugs just isn't very clever
As medical advances endow us with superhuman abilities, we are in danger of losing our humanity (Source: Telegraph Health)
Source: Telegraph Health - August 20, 2015 Category: Consumer Health News Tags: university provigil oxbridge narcolepsy modafinil students oxford smart drugs cambridge Source Type: news

The Truth About This So-Called 'Smart Drug'
By: Laura Geggel Published: 08/19/2015 07:55 PM EDT on LiveScience The "smart drug" modafinil actually does work for some people, improving their performance on long and complex tasks, also enhancing decision-making and planning skills, a new review of studies finds. Modafinil, also known by its brand name Provigil, is approved by the Food and Drug Administration to treat people with sleep disorders such as narcolepsy. But the majority of the drug's users — such as students who take it to study for exams — use it off-label, believing it may help them focus. This is despite the lack of strong evidence ...
Source: Science - The Huffington Post - August 20, 2015 Category: Science Source Type: news

Smart drug Modafinil does work improving memory and learning
The findings raise serious ethical questions about whether modafinil should be ‘classified, condoned or condemned’, University of Oxford and Harvard Medical School experts said. (Source: the Mail online | Health)
Source: the Mail online | Health - August 20, 2015 Category: Consumer Health News Source Type: news

'Smart drug' taken by one in four students really does boost performance
Scientists say it is time to have an ethical debate about whether Modafinil should be 'condoned or condemned.' (Source: Telegraph Health)
Source: Telegraph Health - August 19, 2015 Category: Consumer Health News Tags: Modafinil harvard students oxford smart drug Source Type: news

Narcolepsy medication modafinil is world's first safe 'smart drug'
Increasingly taken by healthy people to improve focus before exams, after a comprehensive review researchers say modafinil is safe in the short-term Modafinil is the world’s first safe “smart drug”, researchers at Harvard and Oxford universities have said, after performing a comprehensive review of the drug. They concluded that the drug, which is prescribed for narcolepsy but is increasingly taken without prescription by healthy people, can improve decision- making, problem-solving and possibly even make people think more creatively.While acknowledging that there was limited information available on the e...
Source: Guardian Unlimited Science - August 19, 2015 Category: Science Authors: Helen Thomson Tags: Drugs Science Neuroscience Source Type: news

Narcolepsy medication modafinil is world's first safe 'smart drug'
Increasingly taken by healthy people to improve focus before exams, after a comprehensive review researchers say modafinil is safe in the short-termModafinil is the world ’s first safe “smart drug”, researchers at Harvard and Oxford universities have said, after performing a comprehensive review of the drug. They concluded that the drug, which is prescribed for narcolepsy but is increasingly taken without prescription by healthy people, can improve decision- ma king, problem-solving and possibly even make people think more creatively.While acknowledging that there was limited information available onthe e...
Source: Guardian Unlimited Science - August 19, 2015 Category: Science Authors: Helen Thomson Tags: Drugs Science Neuroscience Source Type: news

With A $1.2 Billion Hammer,  The FTC Closes Loophole To Prevent Generic Drugs
This morning, the U.S. Federal Trade Commission drew blood: Teva Pharmaceuticals will pay $1.2 billion to reimburse insurers, drug wholesalers, and pharmacies who paid full price for the Provigil, produced by Cephalon, a company Teva bought in 2011, because Cephalon had paid generic drugmakers to delay launching cheaper versions of (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - May 30, 2015 Category: Pharmaceuticals Authors: Matthew Herper Source Type: news

Teva, FTC Reach $1.2 Billion Settlement
Teva Pharmaceutical Industries will pay $1.2 billion to settle government allegations its Cephalon subsidiary paid generic-drug makers to delay competing versions of the sleep-disorder drug Provigil. (Source: WSJ.com: Health)
Source: WSJ.com: Health - May 29, 2015 Category: Pharmaceuticals Tags: PAID Source Type: news

Teva Settles Cephalon Generics Case With F.T.C. for $1.2 Billion
The agency accused the company of illegally blocking generic competition to Provigil, a sleep-disorder drug. (Source: NYT Health)
Source: NYT Health - May 28, 2015 Category: Consumer Health News Authors: REBECCA R. RUIZ and KATIE THOMAS Tags: Provigil Drugs (Pharmaceuticals) Federal Trade Commission Consumer Protection Cephalon Inc. Source Type: news

Teva reaches $1.2B settlement with the FTC
Teva Pharmaceuticals Industries has agreed to pay $1.2 billion to settle charges that Chester County-based Cephalon, which Teva acquired in 2011, illegally blocked the launch of generic versions of its sleep disorder drug Provigil. The settlement reached with the Federal Trade Commission is part of the agency's ongoing efforts to crackdown on "pay-for-delay" deals, under which the makers of brand name prescription drug products allegedly work out agreements with generic drug pharmaceuticals to delay… (Source: bizjournals.com Health Care:Physician Practices headlines)
Source: bizjournals.com Health Care:Physician Practices headlines - May 28, 2015 Category: American Health Authors: John George Source Type: news

U.S. settles 'pay-for-delay' fight with drugmaker Teva over Provigil
WASHINGTON (Reuters) - U.S. antitrust regulators have settled a long-running fight with Cephalon, now owned by Teva Pharmaceuticals, over how it resolved a patent infringement lawsuit tied to wakefulness drug Provigil, the Federal Trade Commission said on Thursday. (Source: Reuters: Health)
Source: Reuters: Health - May 28, 2015 Category: Consumer Health News Tags: healthNews Source Type: news

Teva to lay out $512M to settle pay-to-delay lawsuit
Teva Pharmaceutical Industries Ltd. will pay $512 million to resolve litigation alleging Cephalon — a Chester County biotechnology company Teva bought in 2011 for $6.8 billion — improperly delayed the launch of generic versions of its flagship sleep disorder drug Provigil. A report by Reuters said the proposed settlement is the largest ever to be paid to drug wholesalers and retailers over allegations of delaying generic drugs. The settlement agreement must still be approved by Judge Mitchell… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - April 21, 2015 Category: Biotechnology Authors: John George Source Type: news

Teva to pay $512 million to settle claims of delayed generic Provigil
(Reuters) - Teva Pharmaceutical Industries Ltd has agreed to pay $512 million to settle a class action claiming that Cephalon Inc, which Teva bought in 2011, used anticompetitive settlements to delay generic versions of its wakefulness drug Provigil. (Source: Reuters: Health)
Source: Reuters: Health - April 20, 2015 Category: Consumer Health News Tags: healthNews Source Type: news

Teva to pay $512 million to settle claims of delayed generic Provigil
(Reuters) - Teva Pharmaceutical Industries Ltd has agreed to pay $512 million to settle a class action claiming that Cephalon Inc, which Teva bought in 2011, used anticompetitive settlements to delay generic versions of its wakefulness drug Provigil, according to court papers. (Source: Reuters: Health)
Source: Reuters: Health - April 20, 2015 Category: Consumer Health News Tags: healthNews Source Type: news

Experts Weigh In On The Ethics Of Using Brain-Enhancing Drugs
By: Tanya Lewis Published: March 26, 2015 08:00am ET Boosting a person's smarts through drugs or electrical or magnetic stimulation of the brain is becoming an increasingly widespread practice. Now, bioethicists are weighing in, saying that while such cognitive enhancement is neither bad nor good, it deserves more research. In the past, "there have been many arguments that suggest one should take an ethical stance for or against cognitive enhancement" of healthy individuals, said Amy Gutmann, chairwoman of the Presidential Commission for the Study of Bioethical Issues, which released the second part of a...
Source: Science - The Huffington Post - March 27, 2015 Category: Science Source Type: news

Could modafinil be a drug of dependence? - Dhillon R, Wu X, Bastiampillai T, Tibrewal P.
[Abstract unavailable] Language: en... (Source: SafetyLit: All (Unduplicated))
Source: SafetyLit: All (Unduplicated) - January 23, 2015 Category: Global & Universal Tags: Alcohol and Other Drugs Source Type: news

Letter: Modafinil and Sleep Disorders
No abstract available (Source: Emergency Medicine News)
Source: Emergency Medicine News - December 1, 2014 Category: Emergency Medicine Tags: Letter Source Type: news

Are Modafinil's Brain-Boosting Benefits Hype Or Science?
Modafinil has been approved for treatment of narcolepsy, but it's often used to improve mental performance. The question is, does it work? A new study says probably not.» E-Mail This (Source: NPR Health and Science)
Source: NPR Health and Science - November 17, 2014 Category: Consumer Health News Authors: Maanvi Singh Source Type: news

'Smart drug' modafinil may not make you brainier
Conclusion Modafinil is reported to be frequently used outside of its licensed indication (treatment of narcolepsy) to enhance cognitive performance. This study has cast doubt upon these supposed effects. In this RCT, modafinil slowed responses while having no effect on the accuracy of performance on the Hayling Sentence Completion Test. The exact way modafinil promotes wakefulness is not fully understood. The Hayling Sentence Completion Test is only one measure of cognitive function, and it may be that modafinil has different effects on the performance of different tests. For example, modafinil has been a way to aid conce...
Source: NHS News Feed - November 13, 2014 Category: Consumer Health News Tags: Medication Neurology Source Type: news

‘Smart’ drugs won’t make smart people smarter, research concludes
It is claimed one in five students have taken the ‘smart’ drug Modafinil to boost their ability to study and improve their chances of exam success. But new research into the effects of Modafinil has shown that healthy students could find their performance impaired by the drug.  (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - November 12, 2014 Category: Science Source Type: news

'Smart' drugs won't make smart people smarter
(University of Nottingham) It is claimed one in five students have taken the 'smart' drug Modafinil to boost their ability to study and improve their chances of exam success. But new research into the effects of Modafinil has shown that healthy students could find their performance impaired by the drug. (Source: EurekAlert! - Social and Behavioral Science)
Source: EurekAlert! - Social and Behavioral Science - November 12, 2014 Category: Global & Universal Source Type: news

Modafinil Fails to Improve Fatigue in Cancer PatientsModafinil Fails to Improve Fatigue in Cancer Patients
Modafinil led to a clinically significant improvement in fatigue scores, but there was no significant difference from that seen with placebo. Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - May 8, 2014 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Drug Flunks Test in Cancer-Related Fatigue
(MedPage Today) -- Cancer-related fatigue failed to improve significantly in patients treated with the alertness-promoting drug modafinil, British investigators reported. (Source: MedPage Today Hematology/Oncology)
Source: MedPage Today Hematology/Oncology - April 30, 2014 Category: Hematology Source Type: news

Modafinil improves real driving performance in patients with hypersomnia: a randomized double-blind placebo-controlled crossover clinical trial - Philip P, Chaufton C, Taillard J, Capelli A, Coste O, Leger D, Moore N, Sagaspe P.
STUDY OBJECTIVE: Patients with excessive daytime sleepiness (EDS) are at high risk for driving accidents, and physicians are concerned by the effect of alerting drugs on driving skills of sleepy patients. No study has up to now investigated the effect of m... (Source: SafetyLit: All (Unduplicated))
Source: SafetyLit: All (Unduplicated) - April 24, 2014 Category: Global & Universal Tags: Alcohol and Other Drugs Source Type: news

Terri Reinhart - PARKINSONS
I believe one of the biggest challenges we face with Parkinson's is the management of our therapies. The medical world tends to rely heavily on prescription drugs and surgical procedures such as Deep Brain Stimulation (DBS) to help us control our symptoms. I do not feel qualified to write about DBS surgery as I will not consider this treatment. This was a decision made after much thought, research, and discussions with family and friends. I am sure others will speak on this topic. While I am incredibly grateful for medications which make it possible for me to continue walking and functioning as normally as possible, they a...
Source: PHRMA - March 27, 2014 Category: Pharmaceuticals Authors: Julie Source Type: news

Preliminary evidence for normalization of risk taking by modafinil in chronic cocaine users - Canavan SV, Forselius EL, Bessette AJ, Morgan PT.
Modafinil, a wake-promoting agent used to treat sleep disorders, is thought to enhance cognition. Although modafinil has shown promise as a pharmacotherapy for the treatment of cocaine dependence, it is unknown to what extent cognitive effects may play a r... (Source: SafetyLit: All (Unduplicated))
Source: SafetyLit: All (Unduplicated) - March 27, 2014 Category: Global & Universal Tags: Alcohol and Other Drugs Source Type: news